Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of first‐trimester nuchal translucency on second‐trimester maternal serum biochemical screening for Down's syndrome

1 Oct 1997

Abstract excerpt

We evaluated the effectiveness of 10-14 week nuchal translucency measurement in routine ultrasound screening for Down's syndrome, and its effect on the sensitivity of subsequent maternal serum biochemistry. This was an observational study, in which all women attending for antenatal care at a district general hospital were routinely offered a first-trimester nuchal translucency scan and second-trimester quadruple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9383877
DOI: 10.1046/j.1469-0705.1997.10040261.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of first‐trimester nuchal translucency on second‐trimester maternal serum biochemical screening for Down's syndromePMID 9383877Read ↗

First trimester fetal nuchal translucencySemantic proximity Read ↗

First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucencySemantic proximity Read ↗

First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS)Semantic proximity Read ↗

Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencySemantic proximity Read ↗

Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysisSemantic proximity Read ↗

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?Semantic proximity Read ↗

NUCHAL TRANSLUCENCY CANNOT BE USED AS A SCREENING TEST FOR CHROMOSOMAL ABNORMALITIES IN THE FIRST TRIMESTER OF PREGNANCY IN A ROUTINE ULTRASOUND PRACTICESemantic proximity Read ↗

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practiceSemantic proximity Read ↗

Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk womenSemantic proximity Read ↗

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.Semantic proximity Read ↗

First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.